{"prediction": {"id": "70bab960-d9ba-55ae-853b-d04771c4e463", "work_id": "9197a0e6-942e-56d1-abe2-71831df030bd", "study_id": "90329e99-c5ce-5e43-aaf9-99e27d2c02f4", "kind": "Model evaluation", "pages": [13], "version": "Version of record", "source_work_id": "9197a0e6-942e-56d1-abe2-71831df030bd", "title": "Integrative pan-cancer analysis of dipeptidyl peptidase 4 with clinical and in vitro validation in prostate cancer.", "doi": "10.3389/fimmu.2026.1616889", "pdf_sha256": "903229fcce83a50c8c6a4991a5fd3796ccc44b95b10a165c0bca6b04c2e49bec", "physical_page_count": 23}, "fields": {"measured_variable": {"value": "survival_progression_free", "source_basis": "original_pdf_review", "pages": [1, 13, 17]}, "metric": {"value": "kaplan_meier_group_comparison", "source_basis": "verified_profile", "pages": [13]}, "outcome_target": {"value": "progression_free_survival", "source_basis": "original_pdf_review", "pages": [13]}, "population": {"value": "human_observations", "source_basis": "verified_profile", "pages": [13, 17]}, "prediction_target_type": {"value": "future_clinical_outcome", "source_basis": "original_pdf_review", "pages": [13]}, "reference_type": {"value": "observed_clinical_reference", "source_basis": "verified_profile", "pages": [13]}, "scenario": {"value": "retrospective_cohort_grouping", "source_basis": "verified_profile", "pages": [13]}}, "endpoints": [{"term": "statistical_test", "label": "Statistical test outcomes"}, {"term": "survival", "label": "Survival and mortality"}], "validations": [{"id": "19e1949f-a750-5537-958f-31cd0f8fb3d7", "claim_id": "70bab960-d9ba-55ae-853b-d04771c4e463", "coverage": "direct_comparison", "support": "indeterminate", "source": "same_source", "overlap": "overlap", "comparability": "matched", "statistics": "non_significant", "anchors": [{"work_id": "9197a0e6-942e-56d1-abe2-71831df030bd", "version": "Version of record", "pages": [17]}]}], "model_resources": {"total": 0, "page": 1, "limit": 50, "rows": [], "review_status": "indexed_source"}}